ES2110086T3 - Indoles sustituidos como antagonistas de la angiotensina ii. - Google Patents

Indoles sustituidos como antagonistas de la angiotensina ii.

Info

Publication number
ES2110086T3
ES2110086T3 ES93906123T ES93906123T ES2110086T3 ES 2110086 T3 ES2110086 T3 ES 2110086T3 ES 93906123 T ES93906123 T ES 93906123T ES 93906123 T ES93906123 T ES 93906123T ES 2110086 T3 ES2110086 T3 ES 2110086T3
Authority
ES
Spain
Prior art keywords
lower alkyl
hydrogen
angiotensin
antagonists
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93906123T
Other languages
English (en)
Inventor
Lawrence E Fisher
David E Clarke
Alam Jahangir
Robin D Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/882,390 external-priority patent/US5212195A/en
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Application granted granted Critical
Publication of ES2110086T3 publication Critical patent/ES2110086T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LOS COMPUESTOS DE LA FORMULA (I), (II) O (III) EN DONDE: R1 ES ALKILO INFERIOR CUANDO R2 ES V; O R2 ES ALKILO INFERIOR CUANDO R1 ES V; EN DONDE: V ES (A); R3 ES HIDROGENO O ALKILO INFERIOR; X ES HIDROGENO, ALKILO INFERIOR, HALOGENO, C(O)CF3, -CO2R4 O -C(O)NR5R6; Y ES HIDROGENO, ALKILO INFERIOR, ALCOXI INFERIOR, HIDROXI, HALOGENO O -CO2R4; Z ES HIDROGENO, ALKILO INFERIOR, ALCOXI INFERIOR O HALOGENO; CON LA CONDICION DE QUE Y Y Z NO PUEDEN ESTAR ENLAZADOS AL ATOMO DE NITROGENO DE LA FORMULA (II); EN QUE R4 ES HIDROGENO O ALKILO INFERIOR; R5 ES HIDROGENO, ALKILO INFERIOR O CH2CO2R4; R6 ES HIDROGENO O ALKILO INFERIOR; O R5 Y R6 JUNTOS Y CON EL NITROGENO AL QUE ESTAN UNIDOS REPRESENTAN UN HETEROCICLO; R7 ES (B); (C); (D); (E); (F); (G); (H) O (J); EN QUE: R8 ES -CO2H O 1H-TETRAZOL-5-ILO; Y W ES OXIGENO, AZUFRE O -NR-, EN DONDE R ES HIDROGENO O ALKILO INFERIOR; Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, PRESENTAN PROPIEDADES FARMACOLOGICAS UTILES Y SON PARTICULARMENTE UTILES COMO ANTAGONISTAS DE LA ANGIOTENSINA (II).
ES93906123T 1992-05-13 1993-02-26 Indoles sustituidos como antagonistas de la angiotensina ii. Expired - Lifetime ES2110086T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/882,390 US5212195A (en) 1992-05-13 1992-05-13 Substituted indole antagonists derivatives which are angiotensin II
US08/004,869 US5380739A (en) 1992-05-13 1993-02-04 Substituted indole derivatives

Publications (1)

Publication Number Publication Date
ES2110086T3 true ES2110086T3 (es) 1998-02-01

Family

ID=26673598

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93906123T Expired - Lifetime ES2110086T3 (es) 1992-05-13 1993-02-26 Indoles sustituidos como antagonistas de la angiotensina ii.

Country Status (17)

Country Link
EP (1) EP0640080B1 (es)
JP (1) JP3332234B2 (es)
CN (1) CN1039714C (es)
AT (1) ATE159524T1 (es)
AU (1) AU672599B2 (es)
CA (1) CA2135605A1 (es)
DE (1) DE69314786T2 (es)
DK (1) DK0640080T3 (es)
ES (1) ES2110086T3 (es)
FI (1) FI110512B (es)
GR (1) GR3025118T3 (es)
HU (2) HU221616B1 (es)
IL (1) IL104869A (es)
MX (1) MX9301088A (es)
NO (1) NO308535B1 (es)
NZ (2) NZ249729A (es)
WO (1) WO1993023391A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569539B2 (en) 1996-10-30 2003-05-27 Tetra Level Holdings & Finance S.A. Gas barrier packaging laminate method for production thereof and packaging containers
EA200000868A1 (ru) * 1998-02-25 2001-04-23 Дженетикс Инститьют, Инк. Ингибиторы фосфолипаз
US6828344B1 (en) 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6916841B2 (en) 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
AU1887401A (en) * 1999-12-14 2001-06-25 Nippon Shinyaku Co. Ltd. Medicinal composition
ES2236332T3 (es) * 2000-12-14 2005-07-16 Clariant Gmbh Procedimiento para la preparacion de acidos formil-fenil-boricos.
CZ2004423A3 (cs) * 2001-09-28 2004-08-18 Iharaáchemicaláindustryáco@Źáltd Způsob výroby }@@nitrofenylB acetonitrilových derivátů a meziprodukt použitý pro tuto syntézu
US7713964B2 (en) 2001-12-03 2010-05-11 Wyeth Llc Methods for treating asthmatic conditions
US6984735B2 (en) 2001-12-03 2006-01-10 Wyeth Process for making an aldehyde
US6635771B2 (en) 2001-12-03 2003-10-21 Wyeth N-benzhydryl indole compounds
US7101875B2 (en) 2001-12-03 2006-09-05 Wyeth Methods for treating arthritic disorders
US7605156B2 (en) 2001-12-03 2009-10-20 Wyeth Methods for the use of inhibitors of cytosolic phospholipase A2
US6797708B2 (en) 2001-12-03 2004-09-28 Wyeth Inhibitors of cytosolic phospholipase A2
US7129264B2 (en) * 2003-04-16 2006-10-31 Bristol-Myers Squibb Company Biarylmethyl indolines and indoles as antithromboembolic agents
TW200718687A (en) 2005-05-27 2007-05-16 Wyeth Corp Inhibitors of cytosolic phospholipase A2
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
CA2712854C (en) * 2008-01-31 2016-02-23 Sanofi-Aventis Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
BRPI0906727A2 (pt) * 2008-01-31 2015-08-04 Sanofi Aventis Azaindol-3-carboxamidas cíclicas, sua preparação e seu uso como produtos farmacêuticos
CN101940568B (zh) * 2010-08-17 2012-11-14 合肥博太医药生物技术发展有限公司 吲哚-3-甲醇、二吲哚甲烷及其衍生物在制备治疗蒽环抗癌药引起的心脏衰竭药物中的应用
CN107056781A (zh) * 2017-05-18 2017-08-18 康化（上海）新药研发有限公司 一种(E)‑5‑甲基‑1H‑吡咯并[2,3‑b]吡啶‑3‑甲醛肟的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5124335A (en) * 1991-01-30 1992-06-23 Merck & Co., Inc. Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists

Also Published As

Publication number Publication date
IL104869A (en) 1997-11-20
EP0640080A1 (en) 1995-03-01
ATE159524T1 (de) 1997-11-15
FI945319A7 (fi) 1994-11-11
NO944311D0 (no) 1994-11-11
CN1039714C (zh) 1998-09-09
NO944311L (no) 1994-11-14
GR3025118T3 (en) 1998-01-30
NZ299146A (en) 2000-06-23
IL104869A0 (en) 1993-06-10
CA2135605A1 (en) 1993-11-25
DK0640080T3 (da) 1998-05-25
CN1078469A (zh) 1993-11-17
EP0640080B1 (en) 1997-10-22
JPH07506826A (ja) 1995-07-27
DE69314786D1 (de) 1997-11-27
MX9301088A (es) 1993-11-01
HU210709A9 (en) 1995-06-28
AU672599B2 (en) 1996-10-10
NZ249729A (en) 1996-12-20
DE69314786T2 (de) 1998-02-19
NO308535B1 (no) 2000-09-25
WO1993023391A1 (en) 1993-11-25
JP3332234B2 (ja) 2002-10-07
AU3727493A (en) 1993-12-13
FI945319A0 (fi) 1994-11-11
FI110512B (fi) 2003-02-14
HUT68056A (en) 1995-05-29
HU221616B1 (hu) 2002-12-28

Similar Documents

Publication Publication Date Title
ES2110086T3 (es) Indoles sustituidos como antagonistas de la angiotensina ii.
ES2183905T3 (es) Inhibidores de metaloproteasa de matriz.
ES2067500T3 (es) 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.
ES2120424T3 (es) Derivados substituidos de 1h-3-aril-pirrolidin-2,4-diona.
PE65098A1 (es) Derivados indolicos utiles para terapia
NZ336302A (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
CO4990956A1 (es) Derivados de tienopirimidina y de la tienopiridina utiles comoagentes anticancerigenos
PE2799A1 (es) Lactamas e imidas heterociclicas de aralquilo y aralquilideno
NZ509045A (en) Intermediates in the formation of antivirally active heterocyclic azahexane derivatives
ES2055056T3 (es) Derivados de pirimidopirimidina.
ES2062395T3 (es) Nuevos compuestos de bencimidazol y su uso.
PA8526701A1 (es) Derivados de fenoxibencilamina como ssri
ES2180625T3 (es) Derivados de camptotecina solubles en agua, proceso para su preparacion y su uso como agentes antitumorales.
ES2118333T3 (es) Derivados del acido naftilacetico como agonistas y antagonistas de pgez.
PE75199A1 (es) Derivado de quinolina util como antagonista de neuroquinina
PE69398A1 (es) Antagonistas de receptor de benzoxazinona dopamina d4
ES2168121T3 (es) Derivados de acido 3-amino-2-mercaptobenzoico y procedimientos para su preparacion.
ES2155827T3 (es) 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico.
CO5011117A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos y procedimiento para su preparacion .
PE20010649A1 (es) Derivados de antranilamida de piperidinas 1,4-di-sustituidas como antagonistas muscarinicos
AR246972A1 (es) Un procedimiento para producir compuestos de benzodiazepina, y compuestos intermediarios utiles en dicho procedimiento.
AR009380A1 (es) Proceso de preparacion de un derivado de piridazin-3-ona, util como herbicida, acido carboxilico de utilizacion en el mismo, sal de este ultimo y proceso para preparar dicho acido carboxilico
PE56198A1 (es) Derivados de piperidina
ES8802489A1 (es) Procedimiento para la obtencion de benzamidas
ES2102019T3 (es) 2,3,4,5-tetrahidro-1h-3-benzazepinas y sus sales de adicion farmaceuticamente aceptables.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 640080

Country of ref document: ES